Feb 1310 minOur Parent Company, RespireRx Pharmaceuticals Inc., Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine Glen Rock, N.J., February 13, 2024 /Globe Newswire - RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the...
Jan 229 minOur Parent Company, RespireRx Pharmaceuticals Inc., Announces the Appointment of Dr. Dariusz Naziek to Its Board of DirectorsGlen Rock, N.J., January 22, 2024 /Globe Newswire – RespireRx Pharmaceuticals Inc. (OTC Pink Market:RSPI) (“RespireRx” or the “Company”),...
Dec 11, 20239 minRespireRx and Will Clodfelter to Collaborate on Business DevelopmentRespireRx Pharmaceuticals Inc. Announces Agreement with Ponto Ventures to Drive Business Development with Will Clodfelter as RespireRx...